Vicore Pharma Holding

16,76SEK -1,3 %
1 investor følger denne virksomhed

Vicore Pharma Holding is a pharmaceutical company. The company conducts research and development of molecules with agnostic effect, in industry terms called Renin-Angiotensin System (RAS), which affects the fluid and salt balance in the body. Vicore Pharma usually enters into licensing agreements with other pharmaceutical partners in the industry and has business operations at a global level. The company was founded in 2000 and is headquartered in Gothenburg.

Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
VICO
Daglig lav / høj pris
16,6 / 17 SEK
Markedsværdi
1,37 mia. SEK
Aktieomsætning
348,87 t SEK
Volumen
21 t
Year-end report 2022

Selskabsmeddelelse28.02.2023